Sponsored by

xCures

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1426 to 1450 of about 5944

Previous 25

Website Changes

11/17/2017

Patients Who Used Optune® More Than 90 Percent of the Time Had the Greatest Chance of Survival in Novocure’s EF-14 Trial: A Median Survival of 24.9 Months from Randomization and a Five-Year Survival of 29.3 Percent

11/17/2017

Toca 5 Trial is now open!

11/17/2017

GBM Heroes Honored By CURE

11/16/2017

National Cancer Institute designates UCLA brain cancer program a site of research excellence

11/15/2017

Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma.

11/15/2017

Medicenna Presents Clinical Data From Previous Phase 1 and 2 Clinical Trials of MDNA55

11/10/2017

Human fibulin-3 protein variant expresses anti-cancer effects in the malignant glioma extracellular compartment in intracranial xenograft models

11/07/2017

Liquid Biopsy Spots Aggressive Pediatric Brainstem Cancer Earlier

11/05/2017

Making medicine, not money: How one U of T researcher`s startup is rethinking Big Pharma`s business model

11/05/2017

ONC201 Trial for Histone Mutant Glioma Begins at NYU

11/01/2017

U.S. experts set research agenda to meet `Cancer Moonshot` goals

10/30/2017

Health Beat: MDNA trial for glioblastoma

10/29/2017

10/28/2017

Durable Responses Observed in Recurrent High Grade Glioma (rHGG) with Toca 511 & Toca FC Treatment

10/26/2017

Tocagen to Accelerate Toca 511 & Toca FC Development into Pivotal Phase 3 Trial

10/25/2017

Optune trials opens for adult patients with low grade gliomas and pediatric patients with high grade gliomas

10/24/2017

Incidental findings abound on brain scans of the general pediatric population

10/18/2017

Arsenic identified as a potential treatment for brain cancer

10/18/2017

Diffusion Sprints on FDA Nod for Brain Cancer Treatment

10/18/2017

Clinical trial targets the most common form of brain cancer

10/12/2017

Fake Blogs: Warnings About Medical Advice from Online ‘Experts’

10/11/2017

Immunomic Therapeutics Offers Travel Fund for Clinical Trial Patients

10/11/2017

Areas of glioblastoma tumors correlate with separate subtypes of glioma stem cells

10/11/2017

Mustang CAR-T brain tumor trial gets funds to expand

10/10/2017

Medicenna Presents Clinical Data on Initial Experience from Ongoing Phase 2b Study of MDNA55

Our privacy / cookie policy has changed.
Click HERE to read it!